Advertisement
Singapore markets closed

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • Dow

    38,503.69
    +263.71 (+0.69%)
     

  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     

  • Bitcoin USD

    66,136.33
    +4.11 (+0.01%)
     

  • CMC Crypto 200

    1,434.13
    +10.03 (+0.70%)
     

  • FTSE 100

    8,071.76
    +26.95 (+0.33%)
     

  • Gold

    2,338.80
    -3.30 (-0.14%)
     

  • Crude Oil

    83.11
    -0.25 (-0.30%)
     

  • 10-Yr Bond

    4.6480
    +0.0500 (+1.09%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Did Aurora Cannabis Give Investors Reasons for Hope With Its Fiscal Q4 Results?

Sushree Mohanty, The Motley Fool
·4-min read
Did Aurora Cannabis Give Investors Reasons for Hope With Its Fiscal Q4 Results?

Depsite its dreadful performance over the last two years, investors may still hold out a smudge of hope that things will turn around for Canada-based marijuana producer Aurora Cannabis (NASDAQ: ACB). After all, a cursory glance at its historical stock prices indicates that Aurora did make some investors wealthy in the past. Since it started selling medical cannabis in the first quarter of 2016, Aurora's share price rose by as much as 2,400% through early 2018.

Continue reading